Skip to main content
. 2016 Jun;13(6):816–824. doi: 10.1513/AnnalsATS.201509-603OC

Table 2.

Comparison of participants completing the study with those lost to follow-up

Characteristic Completed 30 d of Follow-Up
Completed 90 d of Follow-Up
Yes (n = 107) No (n = 13) P Value Yes (n = 103) No (n = 17) P Value
Age, yr, median 48 50.6 0.4 48 51 0.4
Female sex 79 (74%) 9 (69%) 0.7 75 (73% 13 (77%) >0.99
African American 97 (91%) 85 0.6 95 (92%) 13 (76%) 0.07
Ever-smoker* 73 (68%) 10 (77%) 0.8 69 (67%) 14 (82%) 0.4
Insufficient vision 15 (14%) 3 (23%) 0.4 13 (13%) 5 (29%) 0.1
Inadequate health literacy 21 (23%) 2 (20%) >0.99 21 (23%) 2 (17%) >0.99
Hospitalized in the last 12 mo, ≥1 time, excluding study period 71 (66%) 8 (62%) 0.8 69 (67%) 10 (59%) 0.6
No provider§ 17 (16%) 4 (31%) 0.2 18 (17%) 3 (18%) >0.99
Near-fatal respiratory event, ≥1 ICU admission or intubation for asthma or COPD 54 (50%) 5 (38%) 0.6 55 (53%) 4 (24%) 0.03
Site, hospital 1 vs. hospital 2 91 (85%) 9 (69%) 0.2 86 (83%) 14 (82%) >0.99
Asthma vs. COPD 76 (71%) 6 (46%) 0.1 73 (71%) 9 (53%) 0.3

Definition of abbreviations: COPD = chronic obstructive pulmonary disease; ICU = intensive care unit.

All data are presented as number (%) unless otherwise indicated. Baseline completers, n = 120; 30-day completers, n = 107 (lost to follow-up, n = 13); 90-day completers, n = 103 (lost to follow-up, n = 17).

*

Ever-smoker was defined as more than 100 lifetime cigarettes versus never-smoker.

Insufficient vision was defined as worse than 20/50 vision in both eyes using the Snellen chart.

Health literacy was assessed in 102 participants with brief intervention (n = 50) or treat-to-goal intervention (n = 52). The remaining subjects had insufficient vision to complete the assessment (n = 18). Less than adequate health literacy was defined as a score of less than 23 of 36 on the Short Test of Functional Health Literacy (24).

§

Did not identify a general physician, specialist physician (pulmonologist or allergist), or nurse practitioner as providing care for participants’ asthma or COPD.